Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 08-2019 | 05-2019 | 02-2019 | 11-2018 | 08-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,796 | 3,467 | 1,594 | 772 | 4,749 |
| Receivables | 5 | 91 | N/A | N/A | N/A |
| TOTAL | $3,200 | $5,369 | $4,468 | $3,928 | $7,540 |
| Non-Current Assets | |||||
| PPE Net | 31 | 29 | 9 | 10 | 12 |
| Intangibles | 14,947 | 15,476 | 15,951 | 16,453 | 1,480 |
| Other Non-Current Assets | 208 | 0 | 0 | 0 | 0 |
| TOTAL | $15,187 | $15,505 | $15,960 | $16,463 | $1,492 |
| Total Assets | $18,387 | $20,874 | $20,428 | $20,391 | $9,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,049 | 16,239 | 14,942 | 18,852 | 20,816 |
| Accrued Expenses | 2,326 | 2,047 | 846 | 930 | 868 |
| Other current liabilities | N/A | 854 | N/A | N/A | N/A |
| TOTAL | $23,067 | $26,926 | $22,259 | $23,983 | $24,139 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,115 | 2,862 | 4,418 | 4,472 | 4,690 |
| TOTAL | $2,115 | $2,862 | $4,418 | $4,472 | $4,690 |
| Total Liabilities | $25,181 | $29,788 | $26,677 | $28,455 | $28,829 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 388,254 | 364,749 | 305,490 | 292,924 | 255,763 |
| Common Shares | 384 | 330 | 305 | 291 | 234 |
| Retained earnings | -245,638 | -229,363 | -214,432 | -201,858 | -187,553 |
| TOTAL | $-6,795 | $-8,914 | $-6,249 | $-8,064 | $-19,797 |
| Total Liabilities And Equity | $18,387 | $20,874 | $20,428 | $20,391 | $9,032 |